Quick Answer
PROVECTUS BIOPHARMACEUTICALS, INC. reported Total Assets of $697.5 thousand for the year ending 2025.
- PROVECTUS BIOPHARMACEUTICALS, INC. showed a decrease of -30.7% in Total Assets from 2024 to 2025.
- This data is from PROVECTUS BIOPHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $20.47 million | Q3 2011: $16.67 million | Q1 2012: $10.45 million | Q2 2012: $9.47 million | Q3 2012: $7.01 million | Q1 2013: $9.27 million | Q2 2013: $9.37 million | Q3 2013: $12.78 million | Q1 2014: $20.79 million | Q2 2014: $22.10 million | Q3 2014: $21.65 million | Q1 2015: $22.77 million | Q2 2015: $31.24 million | Q3 2015: $26.60 million | Q1 2016: $16.02 million | Q2 2016: $10.83 million | Q3 2016: $10.69 million | Q1 2017: $4.51 million | Q2 2017: $4.93 million | Q3 2017: $3.85 million | Q1 2018: $3.06 million | Q2 2018: $3.53 million | Q3 2018: $2.42 million | Q1 2019: $3.69 million | Q2 2019: $2.72 million | Q3 2019: $1.56 million | Q1 2020: $820.0 thousand | Q2 2020: $1.84 million | Q3 2020: $1.34 million | Q1 2021: $771.4 thousand | Q2 2021: $466.3 thousand | Q3 2021: $600.3 thousand | Q1 2022: $2.76 million | Q2 2022: $2.44 million | Q3 2022: $2.05 million | Q1 2023: $1.72 million | Q2 2023: $1.69 million | Q3 2023: $1.69 million | Q1 2024: $1.08 million | Q2 2024: $856.4 thousand | Q3 2024: $802.0 thousand | Q1 2025: $666.3 thousand | Q2 2025: $722.4 thousand | Q3 2025: $419.9 thousand.
- Over the full 16 years of available data (2010 to 2025), PROVECTUS BIOPHARMACEUTICALS, INC.'s Total Assets has declined by 95.2%.
- Historical annual values: Fiscal year 2025: $697.5 thousand | Fiscal year 2024: $1.01 million | Fiscal year 2023: $1.45 million | Fiscal year 2022: $2.04 million | Fiscal year 2021: $3.51 million | Fiscal year 2020: $589.2 thousand | Fiscal year 2019: $1.48 million | Fiscal year 2018: $1.99 million | Fiscal year 2017: $3.44 million | Fiscal year 2016: $5.61 million | Fiscal year 2015: $20.44 million | Fiscal year 2014: $26.18 million | Fiscal year 2013: $20.01 million | Fiscal year 2012: $6.20 million | Fiscal year 2011: $13.35 million | Fiscal year 2010: $14.40 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: